Healthcare Triangle, Inc. What Does Cloud Adoption Look Like in Healthcare? CHIME Survey Reveals Key Trends
While 82% of healthcare IT executives surveyed by CHIME say their organizations rely on the cloud in some way, 47%...
Month: October 2021
Enzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexually Transmitted Infections
GoTestMeNow™ enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis,...
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
EWING, N.J., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today...
SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results Published in Clinical Infectious Diseases Demonstrate Significant Superiority of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
In the Phase 3 VANISH-303 study, ibrexafungerp demonstrated significantly higher rates of clinical cure and infection eradication versus placebo.Post hoc...
Vericel to Report Third-Quarter 2021 Financial Results on November 9, 2021
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Skye Bioscience Sponsored Research Presented at American Association of Pharmaceutical Scientists Meeting PharmSci 360
SAN DIEGO, CA, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a biopharmaceutical...
Mapi Pharma Signs Agreement with Gaelan Medical Trade LLC to Exclusively Market and Distribute Mapi Products in UAE
Photo 1. Above: The signature ceremony in Dubai left to right Ghassan Aboud, Chairman, Ghassan Aboud Group, Ilan Sztulman Starosta,...
ECMOHO Limited Announces Partnership with Vision Care Brand Bausch + Lomb for Sales & Marketing on Pinduoduo
SHANGHAI, China, Oct. 21, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions...
Silence Therapeutics Provides mRNAi GOLD™ Platform and Pipeline Updates at 2021 R&D Day
Silence Therapeutics Provides mRNAi GOLD™ Platform and Pipeline Updates at 2021 R&D Day Announces plans to initiate a Phase 1...
ALR Technologies Releases Select Results from Market Research on Diabetic Pet Industry; Market Demand High for Innovation
GluCurve is the world’s first continuous glucose monitor (CGM) for diabetic dogs and catsGluCurve eliminates need for manual, costly and...
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the...
electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it...
Atreca Enters into Licensing Agreement with Bill & Melinda Gates Medical Research Institute to Develop a Monoclonal Antibody for the Prevention of Malaria
SAN CARLOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on...
Adaptimmune to Report Q3 2021 Financial Results and Business Update on Thursday, November 4, 2021
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy...
Apria to Announce Third Quarter 2021 Financial Results
INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it will...
Athenex to Provide Corporate and Financial Update for the Third Quarter 2021, on November 5, 2021
BUFFALO, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development,...
Solid Biosciences to Participate at the Jefferies Gene Therapy/Editing Summit
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
Revolo Biotherapeutics Activates Clinical Trial and Commences Enrollment in Phase 2 Clinical Study of ‘1104 in Allergic Disease in the UK
NEW ORLEANS and LONDON, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM1 (AAV9-GLB1) Gene Therapy in Patients with GM1 Gangliosidosis
NEW YORK and DURHAM, N.C., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company...
Alimera Sciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021, and Provide Corporate Update
Conference Call to be held Thursday, October 28, 2021, at 9:00am Eastern TimeATLANTA, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Alimera...
